{"schema_version":"secwatch.filing_event.v1","accession":"0001396814-24-000124","form_type":"8-K","ticker":"PCRX","cik":"0001396814","company_name":"Pacira BioSciences, Inc.","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.904388+00:00","generated_at":"2026-05-31T01:06:28.991410+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pacira names Lauren Riker interim CFO; Reinhart departs Sept 30","bullets":["CFO Charles Reinhart departs Sept 30, 2024; will serve as consultant for 9 months.","Lauren Riker, SVP of Finance, appointed interim CFO effective Oct 1, 2024.","Riker's base salary unchanged at $374,700; bonus target 50%; receives one-time $75k bonus.","Riker to serve as interim CFO until permanent successor identified.","No changes to existing employment agreement or other compensation terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001396814-24-000124","json":"https://secwatch.observer/filing/0001396814-24-000124.json","markdown":"https://secwatch.observer/filing/0001396814-24-000124.md","text":"https://secwatch.observer/filing/0001396814-24-000124.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000124/0001396814-24-000124-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000124/pcrx-20240926.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:06:28.991410+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"968a23c5bc","claim":"Charles A. Reinhart, III departed as Chief Financial Officer at Pacira BioSciences, Inc..","evidence_excerpt":"Charles A. Reinhart, III, the Company’s Chief Financial Officer, agreed that he would depart the Company effective September 30, 2024, and will continue to serve as consultant to the Company for a period of nine months thereafter.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000124/0001396814-24-000124-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"depart"},{"label":"Role","value":"Chief Financial Officer"}]},{"claim_id":"f60d2181ca","claim":"Lauren Riker was appointed as interim Chief Financial Officer at Pacira BioSciences, Inc..","evidence_excerpt":"On September 26, 2024, the Board of Directors of the Company (the “Board”) appointed Lauren Riker, the Company’s current Senior Vice President of Finance and principal accounting officer, to also serve as interim Chief Financial Officer of the Company (including as principal financial officer and continuing as principal accounting officer for Securities and Exchange Commission reporting purposes), effective October 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1396814/000139681424000124/0001396814-24-000124-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}